- Market Realist•10 hours ago
Because of its drug portfolio, manufacturing operations, and customer relationships, Teva expects to benefit from new trends in the US generic market.
- Market Realist•17 hours ago
In addition to its generic pharmaceutical business, Teva Pharmaceutical also has a significant presence in the major categories of the OTC drug business.
- Market Realist•18 hours ago
Excluding API sales, in 2016, Teva Pharmaceutical Industries is expected to earn about 50% of its net sales from the North American market.
Teva Pharmaceutical Industries Limited (TEVA)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||49.53 x 200|
|Ask||49.72 x 1200|
|Day's Range||49.30 - 50.57|
|52wk Range||48.01 - 66.55|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||33.05|
|Avg Vol (3m)||5,745,045|
|Dividend & Yield||1.36 (2.71%)|